- Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study.
Kaze AD, Santhanam P, Musani SK, Ahima R, Echouffo-Tcheugui JB. Kaze AD, et al. J Am Heart Assoc. 2021 Apr 6;10(7):e016947. doi: 10.1161/JAHA.120.016947. Epub 2021 Mar 17. J Am Heart Assoc. 2021. PMID: 33728932 Free PMC article. Clinical Trial.
- Granzyme B Expression in Visceral Adipose Tissue Associates With Local Inflammation and Glyco-Metabolic Alterations in Obesity.
Cimini FA, Barchetta I, Ceccarelli V, Chiappetta C, Di Biasio A, Bertoccini L, Sentinelli F, Leonetti F, Silecchia G, Di Cristofano C, Baroni MG, Velotti F, Cavallo MG. Cimini FA, et al. Front Immunol. 2020 Nov 18;11:589188. doi: 10.3389/fimmu.2020.589188. eCollection 2020. Front Immunol. 2020. PMID: 33312176 Free PMC article.
- Novel Insights into the Pathogenesis and Management of the Metabolic Syndrome.
Wang HH, Lee DK, Liu M, Portincasa P, Wang DQ. Wang HH, et al. Pediatr Gastroenterol Hepatol Nutr. 2020 May;23(3):189-230. doi: 10.5223/pghn.2020.23.3.189. Epub 2020 May 8. Pediatr Gastroenterol Hepatol Nutr. 2020. PMID: 32483543 Free PMC article. Review.
- Exposing the Causal Effect of C-Reactive Protein on the Risk of Type 2 Diabetes Mellitus: A Mendelian Randomization Study.
Cheng L, Zhuang H, Yang S, Jiang H, Wang S, Zhang J. Cheng L, et al. Front Genet. 2018 Dec 20;9:657. doi: 10.3389/fgene.2018.00657. eCollection 2018. Front Genet. 2018. PMID: 30619477 Free PMC article.
- A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease.
Scott RA, Freitag DF, Li L, Chu AY, Surendran P, Young R, Grarup N, Stancáková A, Chen Y, Varga TV, Yaghootkar H, Luan J, Zhao JH, Willems SM, Wessel J, Wang S, Maruthur N, Michailidou K, Pirie A, van der Lee SJ, Gillson C, Al Olama AA, Amouyel P, Arriola L, Arveiler D, Aviles-Olmos I, Balkau B, Barricarte A, Barroso I, Garcia SB, Bis JC, Blankenberg S, Boehnke M, Boeing H, Boerwinkle E, Borecki IB, Bork-Jensen J, Bowden S, Caldas C, Caslake M; CVD50 consortium; Cupples LA, Cruchaga C, Czajkowski J, den Hoed M, Dunn JA, Earl HM, Ehret GB, Ferrannini E, Ferrieres J, Foltynie T, Ford I, Forouhi NG, Gianfagna F, Gonzalez C, Grioni S, Hiller L, Jansson JH, Jørgensen ME, Jukema JW, Kaaks R, Kee F, Kerrison ND, Key TJ, Kontto J, Kote-Jarai Z, Kraja AT, Kuulasmaa K, Kuusisto J, Linneberg A, Liu C, Marenne G, Mohlke KL, Morris AP, Muir K, Müller-Nurasyid M, Munroe PB, Navarro C, Nielsen SF, Nilsson PM, Nordestgaard BG, Packard CJ, Palli D, Panico S, Peloso GM, Perola M, Peters A, Poole CJ, Quirós JR, Rolandsson O, Sacerdote C, Salomaa V, Sánchez MJ, Sattar N, Sharp SJ, Sims R, Slimani N, Smith JA, Thompson DJ, Trompet S, Tumino R, van der A DL, van der Schouw YT, Virtamo J, Walker M, Walt… See abstract for full author list ➔ Scott RA, et al. Sci Transl Med. 2016 Jun 1;8(341):341ra76. doi: 10.1126/scitranslmed.aad3744. Sci Transl Med. 2016. PMID: 27252175 Free PMC article.